Analytical and Bioanalytical Chemistry

, Volume 407, Issue 23, pp 7055–7066 | Cite as

Analytical characterization of IgG Fc subclass variants through high-resolution separation combined with multiple LC-MS identification

  • Xiaomei (Annie) He
  • Nathaniel Washburn
  • Enrique Arevalo
  • John H. Robblee
Research Paper

Abstract

With the rapid growth of recombinant monoclonal antibodies and intravenous immunoglobulin (IVIg) medicines, the understanding of human immunoglobulin G (IgG) subclasses becomes more necessary. It is essential to develop effective techniques and methodologies which have the capability for deep characterization. We have created an approach by applying LC and liquid chromatography-mass spectrometry (LC-MS) methods to thoroughly characterize Fc/2 sequence variants for human IgG subclasses in complex samples. Identification and relative quantitation of sequence variants have been provided. Unique glycan information of each IgG subclass can also be obtained by this method. The approach was based on high-resolution HPLC separation followed by intact LC-MS. Peptide mapping was performed following sample fractionation to identify sequence variants. IVIg, a purified IgG mixture from pooled human plasma of thousands of blood donors, was selected as an example for method development. The amino acid sequence variants in IgG Fc/2 constant region were fully investigated for all subclasses by these methods. A total of 19 sequence variants were identified, and their relative abundances were quantitated, which included six variants in IgG1, eight in IgG2, three in IgG3, and two in IgG4. Unique glycan data was also provided for each Fc subclass, which is particularly important for IgG3; glycans from this subclass have only previously been reported together with IgG2 or IgG4. The method described in this paper has been proved to be an effective approach for deep characterization of IgG Fc/2 for complex samples. The findings of IVIg from these studies are also valuable for better understanding of human IgGs.

Graphical Abstract

Identification of sequence variants in IgG Fc mixtures

Keywords

Serum IgGFc LC-MS Sequence variants Glycopeptide Quantitation 

Supplementary material

216_2015_8863_MOESM1_ESM.pdf (121 kb)
ESM 1(PDF 120 kb)

References

  1. 1.
    Giudicelli V, Chaume D, Lefranc MP (2005) IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes. Nucleic Acids Res 33(Database issue):D256–261. doi:10.1093/nar/gki010 CrossRefGoogle Scholar
  2. 2.
    Dam TK, Torres M, Brewer CF, Casadevall A (2008) Isothermal titration calorimetry reveals differential binding thermodynamics of variable region-identical antibodies differing in constant region for a univalent ligand. J Biol Chem 283(46):31366–31370. doi:10.1074/jbc.M806473200 CrossRefGoogle Scholar
  3. 3.
    Dard P, Lefranc MP, Osipova L, Sanchez-Mazas A (2001) DNA sequence variability of IGHG3 alleles associated to the main G3m haplotypes in human populations. Eur J Hum Genet: EJHG 9(10):765–772. doi:10.1038/sj.ejhg.5200700 CrossRefGoogle Scholar
  4. 4.
    Lefranc MP, Lefranc G (2012) Human Gm, Km, and Am allotypes and their molecular characterization: a remarkable demonstration of polymorphism. Methods Mol Biol 882:635–680. doi:10.1007/978-1-61779-842-9_34 CrossRefGoogle Scholar
  5. 5.
    Jefferis R, Lefranc MP (2009) Human immunoglobulin allotypes: possible implications for immunogenicity. MAbs 1(4):332–338CrossRefGoogle Scholar
  6. 6.
    Huck S, Fort P, Crawford DH, Lefranc MP, Lefranc G (1986) Sequence of a human immunoglobulin gamma 3 heavy chain constant region gene: comparison with the other human C gamma genes. Nucleic Acids Res 14(4):1779–1789CrossRefGoogle Scholar
  7. 7.
    Vidarsson G, Dekkers G, Rispens T (2014) IgG subclasses and allotypes: from structure to effector functions. Front Immunol 5:520. doi:10.3389/fimmu.2014.00520 CrossRefGoogle Scholar
  8. 8.
    Rutishauser U, Cunningham BA, Bennett C, Konigsberg WH, Edelman GM (1970) The covalent structure of a human gamma G-immunoglobulin. 8. Amino acid sequence of heavy-chain cyanogen bromide fragments H5-H7. Biochemistry 9(16):3171–3181CrossRefGoogle Scholar
  9. 9.
    Goetze AM, Zhang Z, Liu L, Jacobsen FW, Flynn GC (2011) Rapid LC-MS screening for IgG Fc modifications and allelic variants in blood. Mol Immunol 49(1-2):338–352. doi:10.1016/j.molimm.2011.09.002 CrossRefGoogle Scholar
  10. 10.
    Borrok MJ, Jung ST, Kang TH, Monzingo AF, Georgiou G (2012) Revisiting the role of glycosylation in the structure of human IgG Fc. ACS Chem Biol 7(9):1596–1602. doi:10.1021/cb300130k CrossRefGoogle Scholar
  11. 11.
    Nesspor TC, Raju TS, Chin CN, Vafa O, Brezski RJ (2012) Avidity confers FcgammaR binding and immune effector function to aglycosylated immunoglobulin G1. J Mol Recognit: JMR 25(3):147–154. doi:10.1002/jmr.2155 CrossRefGoogle Scholar
  12. 12.
    Bruhns P, Iannascoli B, England P, Mancardi DA, Fernandez N, Jorieux S, Daeron M (2009) Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood 113(16):3716–3725. doi:10.1182/blood-2008-09-179754 CrossRefGoogle Scholar
  13. 13.
    Ivancic MM, Gadgil HS, Halsall HB, Treuheit MJ (2010) LC/MS analysis of complex multiglycosylated human alpha(1)-acid glycoprotein as a model for developing identification and quantitation methods for intact glycopeptide analysis. Anal Biochem 400(1):25–32. doi:10.1016/j.ab.2010.01.026 CrossRefGoogle Scholar
  14. 14.
    Zhang S, Jiang K, Sun C, Lu H, Liu Y (2013) Quantitative analysis of site-specific N-glycans on sera haptoglobin beta chain in liver diseases. Acta Biochim Biophys Sin 45(12):1021–1029. doi:10.1093/abbs/gmt110 CrossRefGoogle Scholar
  15. 15.
    Qian J, Liu T, Yang L, Daus A, Crowley R, Zhou Q (2007) Structural characterization of N-linked oligosaccharides on monoclonal antibody cetuximab by the combination of orthogonal matrix-assisted laser desorption/ionization hybrid quadrupole-quadrupole time-of-flight tandem mass spectrometry and sequential enzymatic digestion. Anal Biochem 364(1):8–18. doi:10.1016/j.ab.2007.01.023 CrossRefGoogle Scholar
  16. 16.
    Zhu L, Guo Q, Guo H, Liu T, Zheng Y, Gu P, Chen X, Wang H, Hou S, Guo Y (2014) Versatile characterization of glycosylation modification in CTLA4-Ig fusion proteins by liquid chromatography-mass spectrometry. MAbs 6(6):1474–1485. doi:10.4161/mabs.36313 CrossRefGoogle Scholar
  17. 17.
    Ritamo I, Cloutier M, Valmu L, Neron S, Rabina J (2014) Comparison of the glycosylation of in vitro generated polyclonal human IgG and therapeutic immunoglobulins. Mol Immunol 57(2):255–262. doi:10.1016/j.molimm.2013.10.005 CrossRefGoogle Scholar
  18. 18.
    Selman MH, Derks RJ, Bondt A, Palmblad M, Schoenmaker B, Koeleman CA, van de Geijn FE, Dolhain RJ, Deelder AM, Wuhrer M (2012) Fc specific IgG glycosylation profiling by robust nano-reverse phase HPLC-MS using a sheath-flow ESI sprayer interface. J Proteome 75(4):1318–1329. doi:10.1016/j.jprot.2011.11.003 CrossRefGoogle Scholar
  19. 19.
    Zauner G, Selman MH, Bondt A, Rombouts Y, Blank D, Deelder AM, Wuhrer M (2013) Glycoproteomic analysis of antibodies. Mol Cell Proteomics : MCP 12(4):856–865. doi:10.1074/mcp.R112.026005 CrossRefGoogle Scholar
  20. 20.
    Balbin M, Grubb A, de Lange GG, Grubb R (1994) DNA sequences specific for Caucasian G3m(b) and (g) allotypes: allotyping at the genomic level. Immunogenetics 39(3):187–193CrossRefGoogle Scholar
  21. 21.
    Torres M, Casadevall A (2008) The immunoglobulin constant region contributes to affinity and specificity. Trends Immunol 29(2):91–97. doi:10.1016/j.it.2007.11.004 CrossRefGoogle Scholar
  22. 22.
    Torres M, Fernandez-Fuentes N, Fiser A, Casadevall A (2007) The immunoglobulin heavy chain constant region affects kinetic and thermodynamic parameters of antibody variable region interactions with antigen. J Biol Chem 282(18):13917–13927. doi:10.1074/jbc.M700661200 CrossRefGoogle Scholar
  23. 23.
    McCloskey N, Turner MW, Steffner P, Owens R, Goldblatt D (1996) Human constant regions influence the antibody binding characteristics of mouse-human chimeric IgG subclasses. Immunology 88(2):169–173CrossRefGoogle Scholar
  24. 24.
    Chevreux G, Tilly N, Bihoreau N (2011) Fast analysis of recombinant monoclonal antibodies using IdeS proteolytic digestion and electrospray mass spectrometry. Anal Biochem 415(2):212–214. doi:10.1016/j.ab.2011.04.030 CrossRefGoogle Scholar
  25. 25.
    Leblanc Y, Romanin M, Bihoreau N, Chevreux G (2014) LC-MS analysis of polyclonal IgGs using IdeS enzymatic proteolysis for oxidation monitoring. J Chromatogr B Anal Technol Biomed Life Sci 961:1–4. doi:10.1016/j.jchromb.2014.04.053 CrossRefGoogle Scholar
  26. 26.
    Pan H, Chen K, Pulisic M, Apostol I, Huang G (2009) Quantitation of soluble aggregates in recombinant monoclonal antibody cell culture by pH-gradient protein A chromatography. Anal Biochem 388(2):273–278. doi:10.1016/j.ab.2009.02.037 CrossRefGoogle Scholar
  27. 27.
    Dechavanne C, Guillonneau F, Chiappetta G, Sago L, Levy P, Salnot V, Guitard E, Ehrenmann F, Broussard C, Chafey P, Le Port A, Vinh J, Mayeux P, Dugoujon JM, Lefranc MP, Migot-Nabias F (2012) Mass spectrometry detection of G3m and IGHG3 alleles and follow-up of differential mother and neonate IgG3. PLoS One 7(9):e46097. doi:10.1371/journal.pone.0046097 CrossRefGoogle Scholar
  28. 28.
    Lu Q, Padler-Karavani V, Yu H, Chen X, Wu SL, Varki A, Hancock WS (2012) LC-MS analysis of polyclonal human anti-Neu5Gc xeno-autoantibodies immunoglobulin G subclass and partial sequence using multistep intravenous immunoglobulin affinity purification and multienzymatic digestion. Anal Chem 84(6):2761–2768. doi:10.1021/ac2030893 CrossRefGoogle Scholar
  29. 29.
    Ladwig PM, Barnidge DR, Snyder MR, Katzmann JA, Murray DL (2014) Quantification of serum IgG subclasses by use of subclass-specific tryptic peptides and liquid chromatography–tandem mass spectrometry. Clin Chem 60(8):1080–1088. doi:10.1373/clinchem.2014.222208 CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • Xiaomei (Annie) He
    • 2
  • Nathaniel Washburn
    • 1
  • Enrique Arevalo
    • 1
  • John H. Robblee
    • 2
  1. 1.Research DepartmentMomenta Pharmaceuticals Inc.CambridgeUSA
  2. 2.Biosimilars DepartmentMomenta Pharmaceuticals Inc.CambridgeUSA

Personalised recommendations